文献速递临床试验与 GCP

评估远程会诊与面对面会诊安全性比较的随机对照试验研究方案:ECASeT研究

Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study.
PubMed 文献 · Trials · 2023-12-08

ECASeT是一项在西班牙加泰罗尼亚一个行政医疗区域四家中心开展的多中心随机对照试验,旨在评估医院随访中远程会诊(电话或视频)与常规面对面会诊相比的安全性。主要结局为与基线疾病相关的不良反应和并发症数量,目标样本量为每组1068例,招募于2022年5月开始,预计2024年5月结束。

要点

  • 远程会诊(电话或视频)用于医院随访的安全性尚缺乏随机对照试验证据。
  • 主要结局为与基线疾病相关的不良反应和并发症数量。
  • 目标样本量为每组1068例,招募时间为2022年5月至2024年5月。

核心结论

  • 该试验旨在评估远程会诊(电话或视频)在医院随访中的安全性,主要结局为与基线疾病相关的不良反应和并发症数量。

研究设计与样本

  • 多中心随机对照试验,在西班牙加泰罗尼亚一个行政医疗区域的四家中心开展,目标样本量为每组1068例。

关键数值与推荐

  • 主要结局为与基线疾病相关的不良反应和并发症数量。
  • 次要结局包括非计划就诊和住院以及远程会诊的可用性特征。
  • 目标样本量为每组1068例。

局限性

  • 原文指出,采用随机对照设计评估远程会诊模式缺乏先例,这给设计决策(包括招募、选择标准和结局定义)带来了挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of remote consultation modalities has exponentially grown in the past few years, particularly since the onset of the COVID-19 pandemic. Although a huge body of the literature has described the use of phone (tele) and video consultations, very few of the studies correspond to randomized controlled trials, and none of them has assessed the safety of these consultation modalities as the primary objective. The primary objective of this trial was to assess the safety of remote consultations (both video and teleconsultation) in the follow-up of patients in the hospital setting. METHODS: Multicenter, randomized controlled trial being conducted in four centers of an administrative healthcare area in Catalonia (North-East Spain). Participants will be screened from all individuals, irrespective of age and sex, who require follow-up in outpatient consultations of any of the departments involved in the study. Eligibility criteria have been established based on the local guidelines for screening patients for remote consultation. Participants will be randomly allocated into one of the two study arms: conventional face-to-face consultation (control) and remote consultation, either teleconsultation or video consultation (intervention). Routine follow-up visits will be scheduled at a frequency determined by the physician based on the diagnostic and therapy of the baseline disease (the one triggering enrollment). The primary outcome will be the number of adverse reactions and complications related to the baseline disease. Secondary outcomes will include non-scheduled visits and hospitalizations, as well as usability features of remote consultations. All data will either be recorded in an electronic clinical report form or retrieved from local electronic health records. Based on the complications and adverse reaction rates reported in the literature, we established a target sample size of 1068 participants per arm. Recruitment started in May 2022 and is expected to end in May 2024. DISCUSSION: The scarcity of precedents on the assessment of remote consultation modalities using randomized controlled designs challenges making design decisions, including recruitment, selection criteria, and outcome definition, which are discussed in the manuscript. TRIAL REGISTRATION: NCT05094180. The items of the WHO checklist for trial registration are available in Additional file 1. Registered on 24 November 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Rodríguez-Molinero A, Carot-Sans G, Escrig R, et al. Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study. Trials. 2023. PMID: 38066614. doi:10.1186/s13063-023-07679-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。